Ingredient Database | Deep-Researched Cosmetic Ingredients | Roots by Benda
Deep-researched cosmetic ingredient database — MoS calculations, SCCS citations, dermal absorption, sensitization data. Multi-jurisdiction regulatory status.
PTAB Affirms §101 Rejection of Human Milk Product Claims
Patent Trial and Appeal Board Doubles Down on Natural Products Doctrine in Human Milk Case
🥬 Still Avoid the Lettuce: What FDA's Walk-Back Does and Doesn't Mean | Shouldn't Need to Be a Lawyer by Matthew Cortland
Bottom Line Up Front: despite confused reporting and less than clear statements from FDA, Taylor Foods lettuce remains implicated in the Cyc
Paperclip
Paperclip — search, read, and analyze 11M+ biomedical papers, regulatory documents, clinical trials, and biological databases (UniProt, PDB, ChEMBL) from the command line.
Paperclip
Paperclip — search, read, and analyze 11M+ biomedical papers, regulatory documents, clinical trials, and biological databases (UniProt, PDB, ChEMBL) from the command line.
PTAB Affirms § 101 Rejection of Synthetic Milk Sugar Mixture
The Patent Trial and Appeal Board recently affirmed the 35 U.S.C. § 101 rejection of patent claims for a mixture of three human milk oligosaccharides (HMOs), finding the mixture to be ineligible for patenting
Cassava Sciences: Of stocks and blots
A group of anonymous persons filed a Statement of Concern with the FDA regarding the integrity of research papers about Simufilam, an Alzheimer’s Disease treatment drug candidate developed by…
OnCo: the open, cited map of cancer: treatments, targets, trials, and what is coming
The open, cited map of oncology: every cancer, treatment, target, trial, company, institution and idea on one page each, in plain English first, with…
Cosmetics - Guidance, Law & Regulations - Food and Drug Administration, Department of Health
List of Ingredients Restricted in Cosmetic Products (amended list shall become effective from 1 October 2027)
PTAB Reverses § 101 Rejection of Receptor-Derived Peptide Claims
The Patent Trial and Appeal Board (PTAB) Reverses 35 U.S.C. § 101 Subject Matter Eligibility Rejection of Receptor-Derived Peptide Claims
We're thinking about publishing a compendium of #ATScience projects submitted to the workshop (incl abstracts, preprints and published works) - @aaronstevenwhite.io could @chive.pub potentially support that use case?
biblio.livtet.olamaelcu.net is an experimental #appview that: - indexes information about books - allows for authors to claim books Experimental is the truth; it's still going under active review.
biblio.livtet.olamaelcu.net is an experimental #appview that: - indexes information about books - allows for authors to claim books Experimental is the truth; it's still going under active review.
Collection of collections: Health/medicine
Note that I don’t have an actual background on the subject (as is the case with most things, but I thought it’s especially important to mention here)
AI* and healthcare/medicine (by あ) — Semble
Public health (by あ) — Semble
COVID-19 vaccines (by あ) — Semble
Depression (by あ [#F04000]) — Semble
Cancer (unsorted) (by あ) — Semble
COVID-19 history (by あ) — Semble
